Crocetin protects against cardiac hypertrophy by blocking MEK‐ERK1/2 signalling pathway
2008 · Journal of Cellular and Molecular Medicine · 87 citations
https://doi.org/10.1111/j.1582-4934.2008.00620.x
F
Fangfang Yi
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
37
Papers
566
Citations
12
h-index
18
i10-index
Fangfang Yi is an academic researcher from Xuzhou Medical College. The author has contributed to research in topics: Liver Disease Diagnosis and Treatment & Liver Disease and Transplantation & Organ Transplantation Techniques and Outcomes. The author has an h-index of 12, co-authored 32 publications.
ORCID: 0000-0003-0021-823XPapers by this author
worksImpact of gut microbiota on nonalcoholic fatty liver disease: insights from a leave-one-out cross-validation study
2024 · Frontiers in Microbiology · 11 citations
https://doi.org/10.3389/fmicb.2023.1320279
Low-molecular-weight heparin followed by rivaroxaban for acute occlusive portomesenteric vein thrombosis in a cirrhotic patient treated with multiple endoscopic variceal procedures
2019 · Annals of Hepatology · 9 citations
https://doi.org/10.1016/j.aohep.2019.08.002
Nicotine exacerbates MASH via inducing intestinal dysbiosis and barrier dysfunction
2025 · Communications Biology · 0 citations
https://doi.org/10.1038/s42003-025-09280-5
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat